This website uses cookies to function correctly.
You may delete cookies at any time but doing so may result in some parts of the site not working correctly.
 

Noticeboard

RESEARCHOpportunistically - A member of the team may talk to you about a particular study and ask if you would be interested in participating.


Invitation - You may receive information in the post if we feel that you may be a suitable participant.


Asking You may read information in the waiting room and wish to ask a member of staff about how to sign up to a study. 

Open Studies

ALIC4EAn interventional drug study to determine whether adding an antiviral drug is effective in treating flu like illness.

ARCHIEAn interventional drug study for "at risk" children with flu like illness assessing whether antibiotics reduces re-consultation.

ARTIC-PC: An interventional drug study for children aged between 6 months and 12 years old presenting with an acute lower respiratory infection. The study aims to provide evidence to inform the management of chest infections in children and hoping to answer - Should we be giving antibiotics?

BARACK-D: An interventional drug study on patients with known Chronic Kidney Disease.

CONDUCT: A study for women with suspected urinary tract infections comparing urine collection devices.

DECIDE: An interventional drug study for Type 2 Diabetics who need second line treatment to improve diabetic control.

IPTG-01: An interventional study to assess a new antimicrobial cream for the treatment of impetigo.

OPTIMISE: A study to try and optimise blood pressure treatment for Mild Systolic hypertension in the Elderly.

PREDICT: A clinical trial for patients with depression/low mood who need to be started on anti-depression treatment to predict response to that drug.

TEPHRA: Trial of exercise to prevent hypertension in young Adults.

Studies in Follow-Up Phase

OxRen: An observational study on Chronic Kidney Disease.

Past Studies - Closed/Completed

DROPLET: An interventional weight loss study comparing a VLCD vs. NHS standard Weight Loss programme.

BIOTIPP: An interventional study on brain Imaging of Opioid Therapy in Individuals with Persistent Pain.

CANDID: An observational research study into the common early symptoms of bowel and lung cancers.

COMET: A study of Near-patient testing to guide COPD maintenance treatment in primary care.

DARE: A Research study to understand the cause of diabetes (inherited and non-inherited factors), its complication, and to improve treatment.

EDGE: A study for patient to self-manage their COPD using a mobile-health based intervention.

GLOBAL AWARE: A study to estimate the burden of illness in adult atopic dermatitis patients.

HARMONY OUTCOMES: A long term study to determine the effect of albiglutide, when added to standard blood glucose lowering therapies, on major cardiovascular events in patients with Type 2 diabetes mellitus.

HEAT: An interventional study of the bacterium Helicobacter pylori (H. pylori) eradication to prevent ulcer bleeding in aspirin users.

HOME-BP: A study to understand if a web-based programme will assist in patient self-monitoring and management of hypertension.

IDEAL: A longitudinal observational study to Improving the Experience of Dementia and enhancing Active Life.

MERMAIDS-ARI: An observational study for adults with acute respiratory infections to identify host and pathogen related determinants of disease severity.

NOVEL START: A clinical trial investigating the effects of three different inhaler regimens in people with mild asthma.

OAK: An interventional drug study for patients with moderate to severe osteoarthritis of the knee.

PROVE: A clinical trial comparing usual care versus an exercise based intervention versus a manual therapy based intervention - for known Osteoporosis patients.

RIVET: A pilot study run for “INVICTUS” – re-inventing influenza vaccine efficacy trials.

STILTS-2: A study examining common and rare genetic variants associated with thinness.

TASMINH4: An interventional study on telemonitoring and/or self-monitoring of blood pressure in hypertension.

TIME: To investigate the importance of time of dosing in treating hypertension and reducing the risk of cardiovascular events.

TRANSFORM-3: An interventional drug study to evaluate the efficacy, safety, and tolerability of an Intranasal drug Plus an oral antidepressant in adults with Treatment-resistant Depression.

Studies in Set-Up

CEDAR: (Information will be made available soon)

If you have any questions or would like further information about our research studies then please contact Sophie Maslen on 01865 244428. All clinical research carried out is thoroughly checked and approved by ethical committees thus ensuring it is appropriate and safe to perform. Your participation is entirely voluntary and can be withdrawn by yourself at any time without an explanation required. You are under no obligation to participate in any research project that you are invited to take part in. Your care and your relationship with your doctor or nurse will not be affected in any way if you decided not to take part in a research study. You will always receive clear information about what taking part in a research study would involve.  You will have the opportunity to ask questions and obtain further details about a study.

For further information, please visit:

National institute for Health and Research: CRN: Primary Care specialty: http://www.nihr.ac.uk/nihr-in-your-area/primary-care/

Get in touch with INVOLVE, a national group supporting public involvement in research: http://www.invo.org.uk/

People in Research. This site has a searchable database of involvement opportunities: https://www.peopleinresearch.org/

For more general information on patient participation at practice level, please look at http://www.napp.org.uk/

 

 
Call 111 when you need medical help fast but it’s not a 999 emergencyNHS ChoicesThis site is brought to you by My Surgery Website